Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
The prevalence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), increases gradually worldwide in the past decades. IBD is generally associated with the change of the immune system and gut microbiota, and the conventional treatments usually result...
Saved in:
| Main Authors: | Shunyu Yao, Zixi Zhao, Weijun Wang, Xiaolu Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2021/8030297 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01) -
Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at diarrheal variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-05-01) -
Propionibacterium freudenreichii co-inoculation enhances Bifidobacterium longum subsp. longum BB536 growth and metabolite content in soy whey
by: Ricco Tindjau, et al.
Published: (2025-09-01) -
Probiotic Bifidobacterium longum Subsp. longum 51A Protects Mice from Genotoxic and Metabolic Alterations Induced by Subchronic Exposure to a Low-Dose Pesticide Cocktail
by: Mirna Maciel d’Auriol Souza, et al.
Published: (2025-08-01) -
Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study
by: Xiaoya Wang, et al.
Published: (2025-07-01)